25,729 articles
AYUSH-SS granules
AYUSH-SS granules: CCRAS Ayurvedic galactagogue (Shatavari, Shatpushpa, Shweta Jeerak, Sukshma Ela) for insufficient lactation; Delhi randomized trial showed 69.8% vs 44.8% exclusive breastfeeding at six months.
AYUSH-UT ointment
AYUSH-UT ointment (Ayush UT Ointment) is a coded Ayurvedic herbal cream developed by CCRAS, Ministry of Ayush, India, for gynecological disorders; patented in 2006 (1346/DEL/2006), still in the drug-development-in-process stage.
AYUSH-VR oil
AYUSH-VR oil (Ayush VR Oil) is a coded Ayurvedic wound-healing formulation under development by CCRAS, India's Ayurveda research council, as an oil with gel and ointment forms, still in preclinical pharmaceutical development.
Ayushman Bharat Yojana
Ayushman Bharat Yojana (PM-JAY, Ayushman Arogya Mandirs) is India's 2018 universal health coverage initiative: ₹5 lakh per family annual hospitalization cover for the bottom 40%, expanded in 2024 to all citizens aged 70+, plus 150,000 primary care centres.
Azacitidine/venetoclax regimen
The azacitidine/venetoclax regimen pairs azacitidine with the BCL-2 inhibitor venetoclax to treat newly diagnosed acute myeloid leukemia in adults 75 or older or unfit for intensive chemotherapy.
Azapirone
Azapirone is a class of psychoactive drugs, mostly partial agonists at the serotonin 5-HT1A receptor, including buspirone, gepirone, and tandospirone, used mainly for generalized anxiety disorder and studied for depression.
Azaribine
Azaribine (Triazure, CB 304, 6-azauridine triacetate) is a withdrawn oral prodrug of the antimetabolite 6-azauridine, once approved for psoriasis at 125–200 mg/kg/day; not fazarabine.
Azatadine
Azatadine (Optimine, Sch 10649) is a discontinued first-generation sedating H1-antihistamine related to cyproheptadine, developed by Schering-Plough; cat tests wrongly suggested it was nonsedating, and its carbamate derivatives yielded loratadine.
Azathioprine
Azathioprine (Imuran) is a purine-analog immunosuppressant prodrug of 6-mercaptopurine, developed by Hitchings and Elion, used to prevent transplant rejection and treat rheumatoid arthritis, inflammatory bowel disease, lupus, and autoimmune hepatitis, with TPMT/NUDT15-guided dosing and allopurinol interaction.
Azelastine
Azelastine, a phthalazinone H1-antihistamine developed as Asta Pharma compound A 5610, is used as a nasal spray (Astelin, Astepro) for allergic and vasomotor rhinitis, as eye drops for allergic conjunctivitis, and with fluticasone as Dymista.
Azeliragon
Azeliragon (TTP488, PF-04494700) is an oral RAGE antagonist developed by TransTech Pharma and vTv Therapeutics; its Phase 3 Alzheimer's STEADFAST trials failed in 2018, and it is now in oncology trials.
Azelnidipine
Azelnidipine (CS-905, Calblock) is a third-generation dihydropyridine calcium channel blocker for hypertension, launched in Japan in 2003 and approved in China and India; it lowers blood pressure similarly to amlodipine but reduces heart rate instead of raising it.
Azetukalner
Azetukalner (formerly XEN1101, encukalner) is a Xenon Pharmaceuticals Kv7.2/Kv7.3 potassium channel opener for focal seizures; FDA NDA submitted September 2026 after positive X-TOLE phase 2b and phase 3 trials.
Azilsartan
Azilsartan (azilsartan medoxomil, Edarbi) is the eighth angiotensin II AT1 receptor blocker approved for hypertension, FDA-approved 2011, dosed 80 mg daily, with greater SBP-lowering than valsartan and olmesartan and diarrhea as its most common adverse reaction.
Azilsartan medoxomil
Azilsartan medoxomil (TAK-491, Edarbi) is an angiotensin II receptor blocker prodrug for hypertension, FDA-approved February 2011; 40-80 mg once daily, hydrolyzed to active azilsartan, ranked most efficacious ARB at 80 mg.
Azimilide
Azimilide (NE-10064, azimilide dihydrochloride) is an investigational class III antiarrhythmic blocking both IKr and IKs potassium currents, developed by Procter & Gamble, tested in Phase 3 trials for atrial fibrillation and ICD patients but never approved.
Azithromycin
Azithromycin (Zithromax, Sumamed) is a 15-membered azalide macrolide antibiotic synthesized at PLIVA in 1980, FDA-approved 1991; it binds 23S rRNA of the 50S ribosomal subunit and treats respiratory, STI, and enteric infections, with rising mph(A)-mediated resistance.
Azizi Seixas
Azizi Seixas is an American sleep and informatics scientist at the University of Miami, recipient of the 2025 Presidential Early Career Award for Scientists and Engineers.
Azlocillin
Azlocillin (brand Azlin) is a discontinued semisynthetic ureidopenicillin, ATC J01CA09, approved 1982, given parenterally for Pseudomonas aeruginosa infections; eight times as active as carbenicillin against Pseudomonas but inactivated by beta-lactamases.
Azoospermia
Azoospermia, the complete absence of sperm in the ejaculate confirmed by centrifuged pellet examination, divides into obstructive and non-obstructive types; NOA predominates and is treated by TESE with ICSI.
Azotemia
Azotemia: elevated blood urea nitrogen and creatinine, a lab abnormality of kidney or extrarenal origin; classified as prerenal, intrinsic, or postrenal, and called uremia when symptomatic.
Aztreonam
Aztreonam, the only approved monobactam antibiotic (Azactam, Cayston), targets aerobic Gram-negative bacteria including P. aeruginosa, resists metallo-beta-lactamases, and is paired with avibactam against MBL-producing carbapenem-resistant Enterobacterales.
Azygos continuation of the inferior vena cava
Azygos continuation of the inferior vena cava (ACIVC, interrupted IVC with azygos continuation) is a rare congenital venous anomaly: the hepatic IVC segment is absent and lower-body blood drains via a dilated azygos vein to the SVC, often with polysplenia or congenital heart disease.
Azygos vein
The azygos vein is the unpaired vein of the right posterior thorax that drains the thoracic wall, arches over the right main bronchus, and empties into the superior vena cava.
B symptoms
B symptoms: fever above 38°C, drenching night sweats, and over 10% unexplained weight loss in 6 months, used as the A/B suffix in Ann Arbor and Lugano lymphoma staging, now only for Hodgkin lymphoma.
B vitamins
The B vitamins, or B-complex vitamins, are eight water-soluble vitamins, from thiamin to cobalamin, that act mostly as coenzymes in energy metabolism and RNA and DNA synthesis.
B-cell acute lymphoblastic leukemia
B-cell acute lymphoblastic leukemia, also known as precursor B-lymphoblastic leukemia, is a rapidly progressing cancer of the blood and the most common type of acute lymphoblastic leukemia in adults.
B-cell immunodeficiency-limb anomaly-urogenital malformation syndrome
BILU syndrome, also called Hoffman syndrome, is a rare autosomal dominant disorder caused by dominant-negative TOP2B mutations, combining absent B cells with severe hypogammaglobulinemia, distal limb anomalies, urogenital malformations, and facial dysmorphism.
B-cell lymphoma
B-cell lymphomas are malignancies of mature B lymphocytes making up about 85% of non-Hodgkin lymphoma. Covers WHO-HAEM5/ICC 2022 subtypes (DLBCL, follicular, mantle cell, marginal zone, CLL/SLL, Burkitt), genetics, Lugano staging, IPI/FLIPI scores, R-CHOP, CAR-T, and bispecifics.
B-cell prolymphocytic leukemia
B-cell prolymphocytic leukemia (B-PLL), a rare aggressive mature B-cell leukemia with over 55% blood prolymphocytes, splenomegaly, MYC and TP53 aberrations, median survival about 2.8 years; deleted as an entity in WHO-HAEM5 but retained in the ICC.